What does this study add to our knowledge?
There are no reported studies that identify treatment regimens of nitazoxanide for SARS-CoV-2 treatment or prevention. The current study provides evidence-based alternative dosing regimens of nitazoxanide for SARS-CoV-2 treatment and prevention that exceeds antiviral EC90s in key tissues and organs for the duration of the dosing interval.